Study of insulin resistance, TNF-α, total antioxidant capacity and lipid profile in patients with chronic heart failure under exercise

In Vivo

Volumn 25, Issue 6, 2011, Pages 1031-1037

  Tsarouhas, Konstantinos ^a   Tsitsimpikou, Christina ^b   Haliassos, Alexander ^c   Georgoulias, Panagiotis ^d   Koutsioras, Ioannis ^d   Kouretas, Demetrios ^d   Kogias, John ^a   Liosis, Ioannis ^e   Rentoukas, Elias ^f   Kyriakides, Zenon ^e  

^a General Hospital of Karditsa   (Greece)

^b General Chemical State Laboratory   (Greece)

^c ESEAP and Diamedica SA   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

^e RED CROSS HOSPITAL   (Greece)

^f AMALIA FLEMING GENERAL HOSPITAL   (Greece)

Author keywords

Chronic heart failure; Insulin resistance; Lipids; TNF ; Total antioxidant capacity

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PHYSICAL ACTIVITY; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WALKING;

EID: 80755125665     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Jessup M and Brozena S: Heart failure. N Engl J Med 348(20): 2007-2018, 2003.
2. Floras JS: Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54(5): 375-385, 2009.
3. Zimmet JM and Hare JM: Nitroso-redox interactions in the cardiovascular system. Circulation 114(14): 1531-1544, 2006. (Pubitemid 44527009)
4. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW and D'Agostino RB: Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003 107(11): 1486-1491, 2003.
5. Gielen S, Adams V, Linke A, Erbs S, Mobius-Winkler S, Schubert A, Schuler G and Hambrecht R: Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle. Eur J Cardiovasc Prev Rehabil 12(4): 393-400, 2005. (Pubitemid 41192173)
6. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan DE, Satterfield S, Newman AB, Goodpaster B, Bauer DC, Holvoet P, Harris TB, de Rekeneire N, Rubin S, Ding J and Kritchevsky SB: Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 47(8): 1595-1602, 2006.
7. Mehra MR, Uber PA, Lavie CJ, Milani RV, Park MH and Ventura HO: High-density lipoprotein cholesterol levels and prognosis in advanced heart failure. J Heart Lung Transplant 28(9): 876-880, 2009.
8. Kalantar-Zadeh K, Block G, Horwich T and Fonarow GC: Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43(8): 1439-1444, 2004 (Pubitemid 38496352)
9. Lavie CJ and Milani RV: Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era. J Am Coll Cardiol 51(1): 56-58, 2008.
10. Rauchhaus M, Clark AL, Doehner W, Davos C, Bolger A, Sharma R, Coats AJ and Anker SD: The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42(11): 1933-1940, 2003. (Pubitemid 37485568)
11. Sharma R, von Haehling S, Rauchhaus M, Bolger AP, Genth-Zotz S, Doehner W, Oliver B, Poole-Wilson PA, Volk HD, Coats AJ, Adcock IM and Anker SD: Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins. Eur J Heart Fail 7(4): 479-484, 2005. (Pubitemid 40732975)
12. Gaudio G, Guasti L, Schizzarotto A, Simoni C, Crespi C, Cimpanelli M, Klersy C, Grandi AM, Riganti G and Venco A: Changes in plasma lipids during renin-angiotensin system blockade by combination therapy (enalapril plus valsartan) in patients with diabetes and hypertension. J Cardiovasc Pharmacol 45(4): 362-366, 2005. (Pubitemid 40411293)
13. AlZadjali MA, Godfrey V, Khan F, Choy A, Doney AS, Wong AK, Petrie JR, Struthers AD and Lang CC: Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol 53(9): 747-753, 2009.
14. Duncan MH, Singh BM, Wise PH, Carter G and Alaghband-Zadeh J: A simple measure of insulin resistance. Lancet 346(8967): 120-121, 1995.
15. Tenenbaum A and Fisman EZ: Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies. Am J Cardiovasc Drugs 4(5): 269-280, 2004. (Pubitemid 39429834)
16. van Tol BA, Huijsmans RJ, Kroon DW, Schothorst M and Kwakkel G: Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: a meta-analysis. Eur J Heart Fail 8(8): 841-850, 2006. (Pubitemid 44794483)
17. Piepoli MF, Davos C, Francis DP and Coats AJ: Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 328(7433): 189, 2004.
18. Adamopoulos S, Coats AJ, Brunotte F, Arnolda L, Meyer T, Thompson CH, Dunn JF, Stratton J, Kemp GJ and Radda GK: Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 21(5): 1101-1106, 1993. (Pubitemid 23106182)
19. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, Yu J, Adams V, Niebauer J and Schuler G: Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98(24): 2709-2715, 1998. (Pubitemid 28564006)
20. Coats AJ, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi L, Solda PL, Davey P, Ormerod O and Forfar C: Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85(6): 2119-2131, 1992.
21. Pietila M, Malminiemi K, Huupponen R, Rouru J, Pulkki K, Pere E and Voipio-Pulkki LM: Celiprolol augments the effect of physical exercise on insulin sensitivity and serum lipid levels in chronic heart failure. Eur J Heart Fail 2(1): 81-90, 2000. (Pubitemid 30202290)
22. Corvera-Tindel T, Doering LV, Woo MA, Khan S and Dracup K: Effects of a home walking exercise program on functional status and symptoms in heart failure. Am Heart J 147(2): 339-346, 2004. (Pubitemid 38176836)
23. Jolly K, Lip GY, Taylor RS, Raftery J, Mant J, Lane D, Greenfield S and Stevens A: The Birmingham Rehabilitation Uptake Maximization study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. Heart 95(1): 36-42, 2009.
24. Veskoukis AS, Nikolaidis MG, Kyparos A, Kokkinos D, Nepka C, Barbanis S and Kouretas D: Effects of xanthine oxidase inhibition on oxidative stress and swimming performance in rats. Appl Physiol Nutr Metab 33(6): 1140-1154, 2008.
25. Wilund KR, Feeney LA, Tomayko EJ, Weiss EP and Hagberg JM: Effects of endurance exercise training on markers of cholesterol absorption and synthesis. Physiol Res 58(4): 545-552, 2009.
26. Holme I, Aastveit AH, Hammar N, Jungner I and Walldius G: Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein Mortality RISk study (AMORIS). Eur J Heart Fail 11(11): 1036-1042, 2009.
27. Dhingra R, Sesso HD, Kenchaiah S and Gaziano JM: Differential effects of lipids on the risk of heart failure and coronary heart disease: the Physicians' Health Study. Am Heart J 155(5): 869-875, 2008.
28. Buyukyazi G: Differences in blood lipids and apolipoproteins between master athletes, recreational athletes and sedentary men. J Sports Med Phys Fitness 45(1): 112-120, 2005.
29. Lippi G, Schena F, Salvagno GL, Montagnana M, Ballestrieri F and Guidi GC: Comparison of the lipid profile and lipoprotein(a) between sedentary and highly trained subjects. Clin Chem Lab Med 44(3): 322-326, 2006. (Pubitemid 43357693)
30. Kamstrup PR: Lipoprotein(a) and ischemic heart disease - a causal association? A review. Atherosclerosis 211(1): 15-23, 2010.
31. Hopewell JC, Clarke R, Parish S, Armitage J, Lathrop M, Hager J and Collins R: Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study. Circ Cardiovasc Genet 4(1): 68-73, 2011.
32. Koivisto VA, Yki-Jarvinen H and DeFronzo RA: Physical training and insulin sensitivity. Diabetes Metab Rev 1(4): 445-481, 1986.
33. Hsueh WA and Quinones MJ: Role of endothelial dysfunction in insulin resistance. Am J Cardiol 92(4A): 10J-17J, 2003.
34. Tsarouhas K, Karatzaferi C, Tsitsimpikou C, Haliassos A, Kouretas D, Pavlidis P, Veskoukis A, Adamopoulos S, Kyriakides Z, Constantinou L, Koutedakis Y and Rentoukas E: Effects of walking on heart rate recovery, endothelium modulators and quality of life in patients with heart failure. Eur J Cardiovasc Prev Rehabil. Epub ahead of print, Feb 25, 2011.
35. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, Stevenson JC and Coats AJ: Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30(2): 527-532, 1997. (Pubitemid 27339335)
36. Bergamini C, Cicoira M, Rossi A and Vassanelli C: Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail 11(5): 444-452, 2009.
37. Cingolani HE, Piastino JA, Escudero EM, Mangal B, Brown J and Perez NG: The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. J Card Fail 12(7): 491-498, 2006. (Pubitemid 44307706)
38. Esen AM, Akcakoyun M, Esen O, Acar G, Emiroglu Y, Pala S, Kargin R, Karapinar H, Ozcan O and Barutcu I: Uric acid as a marker of oxidative stress in dilatation of the ascending aorta. Am J Hypertens 24(2): 149-154, 2011.
39. Hamaguchi S, Furumoto T, Tsuchihashi-Makaya M, Goto K, Goto D, Yokota T, Kinugawa S, Yokoshiki H, Takeshita A and Tsutsui H: Hyperuricemia predicts adverse outcomes in patients with heart failure. Int J Cardiol 151(2): 143-147, 2011.
40. Straznicky NE, Grima MT, Lambert EA, Eikelis N, Dawood T, Lambert GW, Nestel PJ, Masuo K, Sari CI, Chopra R, Mariani JA and Schleich MP: Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals. J Hypertens 29(3): 553-564, 2011.
41. Dabidi Roshan V, Assali M, Moghaddam AH, Hosseinzadeh M and Myers J: Exercise training and antioxidants: Effects on rat heart tissue exposed to lead acetate. Int J Toxicol 30(2): 190-196, 2011.
42. Kalafati M, Jamurtas AZ, Nikolaidis MG, Paschalis V, Theodorou AA, Sakellariou GK, Koutedakis Y and Kouretas D: Ergogenic and antioxidant effects of spirulina supplementation in humans. Med Sci Sports Exerc 42(1): 142-151, 2010.
43. Desai RV, Ahmed MI, Fonarow GC, Filippatos GS, White M, Aban IB, Aronow WS and Ahmed A: Effect of serum insulin on the association between hyperuricemia and incident heart failure. Am J Cardiol 106(8): 1134-1138, 2010.